HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder 1,400-Product Pipeline Includes Long-Lasting Lip Color, Hair Care

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder is committed to reducing the amount of time it takes to bring new products to market by 30%, according to Senior VP-Research and Development Harvey Gedeon. Speaking at an Estee Lauder analyst meeting in New York City Sept. 17, Gedeon said the company currently has 1,400 projects in development

You may also be interested in...



Clinique Cx To Launch In Neiman Marcus With Premium Prices

Clinique is drawing on its dermatological heritage with Clinique Cx, a three-SKU collection of "high-tech," premium-priced treatment products debuting exclusively in Neiman Marcus in April

Clinique Cx To Launch In Neiman Marcus With Premium Prices

Clinique is drawing on its dermatological heritage with Clinique Cx, a three-SKU collection of "high-tech," premium-priced treatment products debuting exclusively in Neiman Marcus in April

Clinique Mascara Launch Marks Brand’s First Curling Formula

Clinique Lash Curling Mascara, bowing in May, curls lashes up to a 30-degree angle, the Estee Lauder division claims. The product, which provides "curl, definition and long-lasting lift," is Clinique's first mascara positioned primarily for curl enhancement

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010617

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel